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Human saliva emerged as a research material in as early as the 17th century when investigators
sought to understand the basis for salivary secretion (Garrett, 1975). Over the centuries, the focus
of salivary research has evolved greatly and a wide range of topics has been examined (Garrett,
1975; Schipper et al., 2007). It is now known that the functions of saliva include at least lubrication,
digestion of food, remineralization, prevention of demineralization, protection against microbial
and viral infection, speech facilitation, and maintenance of oral and general health (Schipper et al.,
2007; Malathi et al., 2014).
One active research area related to human saliva is the discovery of biomarker molecules
for a variety of diseases. Compared to other body fluids, saliva is easily accessible in a non-
invasive manner. However, it is also immediately exposed to the outside environment, thus may
be confounded by a wide variety of environmental factors. Nevertheless, previous studies have
established that at least some human molecules in saliva are highly stable and potential biomarkers
have been examined for a number of oral and systemic diseases (Bonne and Wong, 2012; Schafer
et al., 2014).
Key Components of Human Saliva
Saliva consists of both cellular and fluid contents. Epithelial cells, leukocytes, and erythrocytes are
the three major human cell types, which co-exist with bacterial cells in human whole saliva (Aps
et al., 2002). The fluid content of saliva is primarily generated by the salivary glands, but with
additional contributions from blood, oral tissue, bacteria, viruses, and food remnants (Schipper
et al., 2007). It mainly consists of water, macromolecules (such as glycoproteins, enzymes), small
organic molecules, inorganic components (e.g., electrolytes), and metabolites from oral bacteria
(Almstahl and Wikstrom, 2003; Aps and Martens, 2005; Schipper et al., 2007).
Many biomarker studies focused on profiling and quantification of proteins or RNA molecules
in saliva. Since the diseases investigated for salivary biomarkers are often systemic, it is of great
interest to identify circulating protein or RNA molecules that may have originated from disease-
relevant cells (such as tumor cells). Such molecules reside outside of the cells in saliva and are often
captured in cell-free saliva (CFS), the fraction of saliva with cellular contents removed (often by
centrifugation). Most of the salivary RNAs appear to be highly degraded compared to full-length
mRNAs in cellular compartments, possibly due to presence of RNA degradation enzymes in saliva
and other body fluids (for circulating mRNAs) (Park et al., 2007). Notably, certain miRNA and
mRNA molecules were shown to be highly stable, possible owing to protection by exosomes or
protein complexes (Park et al., 2006, 2009; Palanisamy and Wong, 2010; Palanisamy et al., 2010).
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Technologies for Salivary RNA Profiling
About a decade ago, microarrays were applied to characterize
the global profile of mRNAs in saliva (Li et al., 2004; Park et al.,
2007). These studies revealed that there were over one thousand
distinct mRNA molecules in human CFS (Li et al., 2004). In
addition to mRNAs derived from coding genes, many noncoding
RNAs (ncRNAs) were also detected. Data from these studies
demonstrate that there are hundreds of microRNAs (miRNAs) in
human saliva, andmost of them likely exist in exosomes (Michael
et al., 2010; Gallo et al., 2012).
However, microarray techniques have inherent limitations,
such as the dependence on gene annotation and cross-
hybridization noise. In recent years, more powerful techniques
based on next generation sequencing (NGS) revealed additional
coding and ncRNA species in human saliva (Spielmann et al.,
2012; Bahn et al., 2015). In contrast to the hybridization-based
microarrays, RNA sequencing (RNA-Seq) offers single nucleotide
information, high sensitivity and accuracy in transcript detection,
and the capability to detect novel RNA species and transcript
isoforms (Lee et al., 2011, 2013; Li et al., 2012). An increasing
number of bioinformatic tools are emerging for analysis of RNA-
Seq data, ranging from rapid short read aligners to detailed
examination of RNA expression patterns (Oshlack et al., 2010).
Owing to these improvements, the catalog of human genes,
especially ncRNA genes, has been greatly expanded (refer to Sai
Lakshmi and Agrawal, 2008; Kozomara andGriffiths-Jones, 2014;
Xie et al., 2014 for ncRNA databases).
ncRNA Molecules in Saliva
In 2012, the Wong group reported the first global
characterization of the human salivary transcriptome using
high-throughput RNA-Seq (Spielmann et al., 2012). This study
demonstrated that saliva harbors a wide variety of RNA species.
More than 4000 distinct RNA molecules derived from coding
or noncoding human RNAs were identified, including a small
number of miRNAs. This study established that the RNA content
in saliva is very diverse, which should be fully explored in future
biomarker studies.
Recently, another in-depth analysis of human salivary
extracellular ncRNA revealed novel insights regarding its RNA
content and provided a comparative view of salivary ncRNAs
relative to those of other body fluids (Bahn et al., 2015). Using
human CFS, this study confirmed previous findings that miRNAs
are stably and abundantly present in saliva (Patel et al., 2011),
often harbored within exosomes (Gallo et al., 2012). miRNA
expression profiles of healthy individuals were quantified and
compared. Highly concordant miRNA expression was observed
across individuals. Furthermore, considerable similarity was
observed between miRNA expression levels of saliva and other
body fluids (blood, cerebral spinal fluid (CSF)). Thus, these
data suggest that salivary miRNAs could serve as candidate
biomarkers, at least with equivalent promise as those derived
from more invasive fluids.
A surprising observation from this study was the relative
abundance of human piwi-interacting RNAs (piRNAs) in saliva.
piRNAs are small ncRNAs typically∼26–32 nt in length observed
in germ cells of both vertebrates and invertebrates (Aravin et al.,
2006; Girard et al., 2006; Grivna et al., 2006; Lau et al., 2006;
Watanabe et al., 2006; Das et al., 2008). piRNAs are known
to target transposons and repress their mobility (Das et al.,
2008; Malone and Hannon, 2009). The number of abundant
piRNAs is less than that of miRNAs in saliva, despite the
large number of annotated piRNAs in various databases (Sai
Lakshmi and Agrawal, 2008; Bahn et al., 2015). Nevertheless,
piRNA expression levels were highly concordant between healthy
individuals, similarly as miRNA levels. However, in contrast to
the consistent expression profile of miRNAs across body fluids,
piRNAs were highly exclusive to saliva with very low abundance
in blood or CSF. These observations indicate that salivary
piRNAs may have originated from cells in the oral mucosa or
salivary glands, rather than circulating from systemic organs
via blood. Nevertheless, salivary piRNAs may impose systemic
functional impact, which needs to be further investigated.
Another novel finding in this study was the discovery of
circular RNAs (circRNAs) in CFS, which is the first report of the
presence of circRNAs in an extracellular fluid (Bahn et al., 2015).
CircRNAs were originally identified in RNA viruses (Sanger et al.,
1976; Kos et al., 1986). Later, intracellular circRNAs generated
from specific exons of coding genes were reported (Nigro et al.,
1991; Cocquerelle et al., 1992; Capel et al., 1993). Recent studies
demonstrated that circRNAs exist inmany different cell types and
species (Salzman et al., 2012, 2013; Jeck et al., 2013; Memczak
et al., 2013). Some circRNAs are likely noncoding (Capel et al.,
1993; Memczak et al., 2013; Guo et al., 2014), but others may
code for proteins (Wang and Wang, 2015). The function of
most circRNAs remains unknown. Two circRNAs were shown to
function as miRNA sponges (Hansen et al., 2013; Memczak et al.,
2013). However, this function may not apply to the majority of
other circRNAs as they lack bioinformatic evidence of significant
miRNA complementarity (Guo et al., 2014). The discovery of
circRNAs in CFS indicates that this type of molecule may have
extracellular function and should be considered as a type of
candidate biomarker (Li et al., 2015).
Although mRNAs are highly degraded in saliva and other
body fluids, small ncRNAs are often stable with reproducible
expression across individuals. Indeed, miRNAs have been
extensively studied in blood and other body fluids as potential
disease biomarkers (Chen et al., 2008; Gilad et al., 2008; Mitchell
et al., 2008; Wang et al., 2009, 2010; Fichtlscherer et al., 2010;
Li et al., 2010; Liu et al., 2011). The similarity between miRNA
profiles of saliva and other body fluids (Weber et al., 2010; Bahn
et al., 2015) strongly supports the potential of using miRNAs
(and possibly other ncRNAs) from human CFS as biomarkers for
various human diseases.
Salivary ncRNAs as Potential Biomarkers
for Diseases
Although at an early stage, salivary ncRNA studies have revealed
potential disease biomarkers. Thus, far, most studies focused on
miRNA expression in saliva. Table 1 summarizes a number of
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TABLE 1 | Potential salivary miRNA biomarkers in cancer.
miRNAa AUCb p-value Up/Down-regulatedc Statistical test
HEALTHY CONTROL VS. ORAL SQUAMOUS CELL CARCINOMA (Park et al., 2009)
miR-200a 0.65 0.01 Down Mann-Whitney U
miR-125a 0.62 0.03 Down Mann-Whitney U
BENIGN VS. MALIGNANT PAROTID GLAND TUMORSd (Matse et al., 2013)
miR-132 0.9 0.003 Up Wilcoxon 2-sided
miR-15b 0.9 0.0019 Up Wilcoxon 2-sided
miR-140-5p 0.9 0.0003 Up Wilcoxon 2-sided
miR-223 0.9 0.0542 Up Wilcoxon 2-sided
HEALTHY CONTROL VS. ESOPHAGEAL CANCER (Xie et al., 2013)
miR-10b-3p 0.702 0.013 Up (4.5) Mann-Whitney U or Kruskall-Wallis H
miR-144 0.671 0.036 Up (6.7) Mann-Whitney U or Kruskall-Wallis H
miR-21 0.698 0.015 Up (9.7) Mann-Whitney U or Kruskall-Wallis H
miR-451 0.725 0.006 Up (5.4) Mann-Whitney U or Kruskall-Wallis H
HEALTHY CONTROL VS. RESECTABLE PANCREATIC CANCER (Xie et al., 2015)
miR-3679-5p 0.673 0.008 Down (2.162) Mann-Whitney U
miR-940 0.68 0.006 Up (2.586) Mann-Whitney U
BENIGN PANCREATIC TUMORS VS. RESECTABLE PANCREATIC CANCER (Xie et al., 2015)
miR-3679-5p 0.716 0.007 Down (4.708) Mann-Whitney U
miR-940 0.729 0.004 Up (3.02) Mann-Whitney U
HEALTHY CONTROL AND BENIGN PANCREATIC TUMORS VS. RESECTABLE PANCREATIC CANCER (Xie et al., 2015)
miR-3679-5p 0.688 0.002 Down (3.012) Mann-Whitney U
miR-940 0.696 0.0001 Up (2.716) Mann-Whitney U
aValidated by qRT-PCR.
bArea under Receiver Operating Characteristic (ROC) curve.
cChange in disease relative to control. The number in the parentheses represents the fold change.
dA combination of four miRNA exhibits discriminating power.
studies where miRNAs were assessed as putative biomarkers for
oral squamous cell carcinoma (OSCC) (Park et al., 2009), parotid
gland tumors (Matse et al., 2013), and esophageal cancer (Xie
et al., 2013). In addition to oral and esophageal diseases, salivary
ncRNAs were also examined as potential biomarkers for systemic
diseases. In a clinical study focusing on Sjögren’s Syndrome,
a chronic autoimmune disease, the authors observed different
miRNA expression patterns in minor salivary glands of Sjögren’s
Syndrome patient compared to healthy individuals (Alevizos
et al., 2011). The disease group can be clearly distinguished
from the normal group using the miRNA expression profile by
principal components and hierarchical clustering analyses. A
very recent study focused on pancreatic cancer, using samples
of patients with pancreatic cancer, benign pancreatic tumor
or healthy controls (Xie et al., 2015). The authors observed
significant down-regulation of miR-3679-5p and up-regulation
of miR-940 in the cancer group compared to the other groups
(Table 1), suggesting salivary miRNAmay potentially be used for
early detection of pancreatic cancer.
In addition to human ncRNAs, exogenous ncRNAs in saliva
may also serve as potential disease biomarkers. The human-
associated microbial communities have profound impact on
the individual’s physiological outcome (Human Microbiome
Project Consortium, 2012). In human saliva, over 1500 bacteria
have been identified and completely sequenced [Human Oral
Microbiome Database; http://www.homd.org/]. Some studies
have shown that saliva can be used to detect microbial infection
(Schafer et al., 2014). In addition, both DNA and RNA viruses
were detected in human saliva from viral infected hosts (Liou
et al., 1992; Chen et al., 1997; Vieira et al., 1997; Shugars et al.,
2001; Hermida et al., 2002; Mackiewicz et al., 2004; Goncalves
et al., 2005; Balamane et al., 2010; Pride et al., 2012), thus could
serve as biomarkers of viral infection. Thus, far, little is known
regarding the landscape and function of exogenous ncRNAs in
saliva.
Future Challenges and Perspectives
A comprehensive ncRNA expression profile is emerging for
human saliva including the presence of miRNAs, piRNAs, and
circular RNAs (Ogawa et al., 2013; Bahn et al., 2015). More RNA
species may be discovered in the future given the rapid evolution
of new technologies and powerful bioinformatic methods. The
value of saliva as a body fluid for biomarker discovery is just
becoming widely recognized. However, there are a number of
challenges in this field, most of which are general to usage
of any body fluid in biomarker discoveries. One challenge lies
in the unbiased isolation of short and long RNA molecules
from saliva samples. Although this topic is under intensive
investigation, improved methods that can retain most RNA
species unbiasedly in an operator-independentmanner are highly
desired.
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Another challenge is accurate quantification of ncRNA
abundance, which is key to biomarker assessment. RNA yield
from different samples may vary greatly, which calls for effective
experimental and bioinformatic methods for normalization
of RNA expression. Most RNA-Seq studies discussed above
calculated RNA expression levels by normalizing the number of
reads of a particular RNA molecule against the total number
of mapped reads (i.e., the RPKM measure Mortazavi et al.,
2008). However, to estimate the absolute concentration of an
RNA molecule in a sample, synthetic spike-in RNAs with known
concentration should be added to the RNA sample before library
generation. This approach necessitates accurate measurement
of RNA concentration of the sample and synthesis of a large
number of spike-in RNAs with varying sequence contents and
concentrations (see Williams et al., 2013 for a demonstration
of this approach). This challenging approach, though highly
desirable and necessary for clinical usage of a biomarker, has not
been widely adopted.
A third major challenge is a better understanding of
the biogenesis pathways of human ncRNAs in saliva, which
constitutes the basis to assess whether and to what extent
ncRNA expression can reflect a person’s health condition.
Salivary RNAs could be derived from systemic organs or
local cells of the oral cavity. Cellular origins of candidate
biomarkers for various diseases should be further examined to
substantiate our understanding of the validity of the biomarkers.
Indeed, the presence, origin, and functional roles of disease
biomarkers are all essential questions general to studies of
different types of biomarkers and diseases. A valid disease
biomarker should be directly involved in disease mechanisms
or indirectly associated/correlated with key pathways driving
the pathogenesis of disease. The ultimate question is how
knowledge gained in biomarker studies could be utilized to
develop effective strategies for disease prevention and treatment,
which closely relies on a clear understanding of disease
mechanisms.
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